Side Effects & Safety Mild GI discomfort most common, usually transient in the first week Slight stimulant effect increased energy/alertness, especially early on Headaches occasional, typically mild and dose-related Mild insomnia if taken too late in the day No human clinical safety data all safety information from preclinical studies and community reports No liver toxicity observed in animal studies at therapeutic doses Unknown drug interactions theoretically could interact with NAD+-dependent pathways Core Supplies for This Protocol The three essentials for running any reconstituted injectable: cold storage, accurate syringes, and metabolic tracking
Its targeted mechanism makes AOD-9604 Peptide a widely discussed compound in metabolic and weight management research models
What the evidence does not establish: Human efficacy at clinically meaningful magnitudes, long-term safety, cardiovascular profile under chronic dosing
For a 250 mcg dose, this requires drawing 0.1 mL (10 units on an insulin syringe) of the reconstituted solution
This injection has been a life-changer for me
Association Between Folate and Health Outcomes: An Umbrella Review of Meta-Analyses
